Study of ziconotide pain treatment in routine care
Treatments studied
Part of Pain clinical trials.
This study follows adults with severe, long-lasting pain that has not responded to other treatments, to see how the pain medicine ziconotide works in everyday clinical practice. You may be considered if you’re being evaluated for an implanted pain-delivery system that gives ziconotide into the spinal fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have severe chronic pain that has not improved with other treatments
- Be a candidate for an implanted system that delivers pain medicine into the spinal fluid (intrathecal therapy)
- Be planned to receive ziconotide as part of that spinal-fluid pain treatment
- Understand the study and agree to join
- Do not have medical reasons you cannot safely take ziconotide
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a medicine called ziconotide, given through a pump in your spine (intrathecal delivery) to treat chronic pain that is not from cancer. It aims to learn how safe and effective this treatment is in real-world patients.
This study tests a drug called ziconotide, given through a pump that delivers it directly into the fluid around your spinal cord, to see if it can help with nerve pain caused by chemotherapy. The drug is already approved for severe chronic pain, but this research focuses on chemotherapy-related nerve pain.
This study tests an experimental drug called ITX24-01 for people with severe, long-term neck or lower back pain that comes from the small joints in the spine. If you're already planning to have a procedure called radiofrequency ablation (RFA) to treat this pain, this trial may help you by testing if the drug can improve your pain relief.
This trial tests a medicine called CNTX-3001, given as a spinal injection, for people with long-term, severe low back pain that hasn't improved with other treatments.
This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.
This study follows people receiving Inceptiv, a spinal cord stimulator from Medtronic, to see how well it works over time. It is for adults with chronic back or limb pain who have not tried spinal cord stimulation before.
Hear when a new Refractory Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.